Who makes BIIB021 and Food?

BIIB021 and Food is developed by Biogen.

What development phase is BIIB021 and Food in?

BIIB021 and Food is in Phase 1.

Last reviewed 2026-04-19 · How we verify

BIIB021 and Food

Biogen · Phase 1 active Small molecule

At a glance

Generic name	BIIB021 and Food
Sponsor	Biogen
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BIIB021 and Food CI brief — competitive landscape report
BIIB021 and Food updates RSS · CI watch RSS
Biogen portfolio CI